Windtree Therapeutics, Inc.
WINT
$0.456
$0.08623.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.66% | -10.38% | -11.68% | -14.36% | -10.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.19% | 41.41% | 62.15% | 67.10% | 6.96% |
| Operating Income | -34.19% | -41.41% | -62.15% | -67.10% | -6.96% |
| Income Before Tax | -176.57% | 91.16% | 63.21% | 57.13% | 84.01% |
| Income Tax Expenses | -205.26% | -- | 105.19% | 122.75% | 108.34% |
| Earnings from Continuing Operations | -169.27% | 91.19% | 60.90% | 53.46% | 83.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -169.27% | 91.19% | 60.90% | 53.46% | 83.06% |
| EBIT | -34.19% | -41.41% | -62.15% | -67.10% | -6.96% |
| EBITDA | -33.85% | -41.08% | -61.91% | -67.18% | -7.06% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |